COO
The Cooper Companies Inc
Q2 2025 Report
The Cooper Companies Inc (COO) Q2 2025 Financial Results: Steady Growth in a Dynamic Market...
Read full report
Executive Summary
The Cooper Companies Inc reported robust financial results for the first quarter of fiscal year 2025, showcasing record revenues of $965 million, representing a year-over-year increase of 4%, and an organic growth of 5%. This growth was primarily driven by CooperVision, which achieved $646 million in revenue, reflecting a 4% increase and a 6% organic growth. Meanwhile, CooperSurgical generated $319 million in revenue, up 3% and 2% organically. The management reported strong operating performance with non-GAAP earnings per share rising to $0.92, driven by improved gross margins and operational efficiencies despite facing challenges in certain markets, particularly in China. The company's strategic investments in its MyDay product line are expected to facilitate further growth as production constraints loosen and new product launches are on the horizon.
Key Performance Indicators
Revenue
964.70M
QoQ: -5.27% | YoY:3.55%
Gross Profit
660.20M
68.44% margin
QoQ: 5.21% | YoY:15.12%
Operating Income
182.00M
QoQ: -8.27% | YoY:18.88%
Net Income
104.30M
QoQ: -11.23% | YoY:28.45%
EPS
0.52
QoQ: -11.86% | YoY:26.83%
Revenue Trend
Margin Analysis
Key Insights
**Revenue Growth:** 4% YoY, 5% organic; **Gross Profit:** $660.2 million, Gross Margin 68.7% (up from 67.3%); **Operating Income:** $182 million; **Net Income:** $104.3 million; **EPS:** $0.92; **Free Cash Flow:** $101 million; **Net Cash Provided by Operating Activities:** $190.6 million; **Capital Expenditure:** -$89.4 million. Key drivers of revenue included a 20% increase in the myopia management portfolio, particularly with MySite, which grew 27% and established CooperVision's market l...